BlackRock, Inc. Reports 9.8% Ownership in THARIMMUNE INC

BlackRock, Inc. has filed a Schedule 13G with the SEC, reporting a 9.8% ownership in THARIMMUNE INC. The filing indicates that BlackRock beneficially owns 663,882 shares of common stock in THARIMMUNE INC. The shares are held in the ordinary course of business and are not intended to influence the control of the issuer. The filing also notes that the interest of TSP S Fund - Small Cap Stock Index Investment Fund Account in the common stock of THARIMMUNE INC is more than five percent of the total outstanding common stock. The filing was signed by Spencer Fleming, Managing Director of BlackRock, Inc., on October 17, 2025.